DIN 02456370 — EPCLUSA 400 MG; 100 MG
EPCLUSA is a tablet of Sofosbuvir / Velpatasvir marketed by GILEAD SCIENCES CANADA INC. The full Sofosbuvir / Velpatasvir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456370
- Brand name
- EPCLUSA
- Active ingredient
- Sofosbuvir / Velpatasvir
- Strength
- 400 MG; 100 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Direct-acting antiviral combination (NS5B polymerase inhibitor + pan-genotypic NS5A inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.